Clinical Trials Logo

Filter by:
NCT ID: NCT05805059 Completed - Myopia Clinical Trials

Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses.

Start date: April 14, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to compare the performance of two daily disposable silicone hydrogel contact lenses.

NCT ID: NCT05804981 Completed - Clinical trials for Cognitive Impairment

Early Detection of Cognitive Decline

EDCD
Start date: June 8, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the impact of a brief cognitive screener on provider behavior in patients completing an annual wellness visit (AWV). The main question[s] it aims to answer are: - do appropriate referrals increase for patients using the new screener? - do appropriate diagnostic orders increase for patients using the new screener? Participants will respond to 4 questions about their cognitive abilities as part of a larger AWV protocol. Researchers will compare provider behavior for patients completing AWVs before and after implementation of the new screener to see if referral, diagnostic and prescribing behaviors differ.

NCT ID: NCT05804825 Completed - Vaccine Refusal Clinical Trials

Testing the Persuasiveness of Pro-inoculation Arguments

Start date: May 4, 2023
Phase: N/A
Study type: Interventional

The investigators will recruit a national sample of parents of 7-10-year-olds to complete an argument strength ranking for either a simple forwarding message or between 3 and 6 randomly selected arguments from an overall set of 50 to 100 messages identified from various online sources. Parents will rate each message they see on measures of perceived argument strength/PME. Parents will also answer sociodemographic questions and then rank the believability of a set of anti-vaccine messages identified in a different study. Study findings will contribute valuable information to understanding the effectiveness of different inoculation messages.

NCT ID: NCT05804500 Completed - Clinical trials for Coronary Artery Disease

RecoveryPlus Telerehab Platform Pilot Study

Start date: March 27, 2023
Phase: N/A
Study type: Interventional

In this prospective, single-arm study, we will look at the initiation, participation, sustained engagement, and safety of 100 adult subjects (ages 45 years or older) with recent (within the past 60 days) clinician referral to CR who are offered CTR via the RecoveryPlus platform. We want to understand the effectiveness of the RecoveryPlus platform in engaging participants in CR while remaining a safe alternative for the delivery of evidence-based CR content. The primary hypothesis of this study is that the RecoveryPlus CTR platform and patient-facing mobile application provide a safe alternative to traditional in-person CR, and demonstrate a high rate of initiation, participation, and engagement in CR exercise programming than traditional modes of CR delivery, as documented in the literature. Current in-person and non-personalized CR programming lacks RecoveryPlus' convenient remote access, easy-to-use digital tools to support independent, autonomous exercise, and a platform to facilitate engagement and feedback between patients and EPs.

NCT ID: NCT05803850 Completed - IPF Clinical Trials

A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058

Start date: March 28, 2023
Phase: Phase 1
Study type: Interventional

The purpose of this First-in-Human study is to evaluate the safety and tolerability after single ascending oral doses of HNC1058 given to healthy subjects, compared to placebo.

NCT ID: NCT05803603 Completed - Clinical trials for Opioid-Related Disorders

Social Work Assistance and Stipends for Housing (SASH)

SASH
Start date: December 1, 2022
Phase: N/A
Study type: Interventional

SASH is a clinical trial feasibility study that will provide an intervention to improve Opioid Use Disorder (OUD), Quality of Life (QOL), and housing outcomes for homeless patients receiving Medication for Opiate Use Disorder (MOUD). The main questions of the study are does a $500 housing stipend for individuals on MOUD increase treatment retention, improved quality of life and prevent homelessness.

NCT ID: NCT05803200 Completed - Clinical trials for Exposure During Pregnancy

A Study to Describe Mothers' and Babies' Outcomes After Exposure to HyQvia During Pregnancy

Start date: March 15, 2023
Phase:
Study type: Observational

The main aim of this study is to provide further information on the safety profile of HyQvia during pregnancy. This will be done by checking the characteristics of the mother and their babies. They will also be checked for any safety outcomes that will occur when exposed to HyQvia during pregnancy.

NCT ID: NCT05803096 Completed - Prostate Cancer Clinical Trials

Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain

Start date: December 12, 2021
Phase: Phase 4
Study type: Interventional

Transrectal prostate biopsy is a commonly performed ambulatory procedure for diagnosing prostate cancer. Prostate biopsy are associated with pain or anxiety. Nitrous oxide (or laughing gas) is a well-known inhaled anesthetic which is frequently used in dental offices and for pediatric procedures to alleviate a patient's anxiety and pain. This study seeks to determine whether administration of nitrous oxide at the time of prostate biopsy will improve a patient's experience of care.

NCT ID: NCT05802901 Completed - Clinical trials for Non-specific Low Back Pain

The Effect of Combining Spinal Manipulation and Dry Needling in Individuals With Low Back Pain

SMTDNLBP
Start date: February 28, 2021
Phase: N/A
Study type: Interventional

The goal of this study is to enroll and randomize 99 participants with non-specific low back pain into a multimodal strategy of treatment consisting of a combination of dry needling (DN) and spinal manipulation therapy (SMT), DN only, and SMT only, followed by an at home exercise program. All groups will receive their respective treatment twice a week for 2 weeks followed by a 2-week home exercise program. Primary outcomes include clinical subjective (Oswestry Disability Index, numeric pain intensity rating) and mechanistic (lumbar multifidus, erector spinae, and gluteus medius muscle activation) measures assessed at baseline, 1, 2, and 4 weeks. Timepoints at 2-weeks and 4-weeks will be compared to baseline measures to determine effectiveness of the combination group against the other single treatment groups. Exercise compliance will be measured by participants self-reporting adherence to the program by selecting average number of days per week the exercises are completed.

NCT ID: NCT05802173 Completed - Clinical trials for Alopecia, Androgenetic

Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia

Start date: March 6, 2023
Phase: Phase 2
Study type: Interventional

Randomized, double-blind, vehicle-controlled, parallel group, multi-dose study of TDM-105795 in male subjects with androgenetic alopecia